A Research Study to Compare the Effect of Insulin Degludec and Insulin Glargine on Blood Sugar Levels in People With Type 2 Diabetes - the SWITCH PRO Study
Clinical trial NCT03687827 · COMPLETED
Trial details
- NCT number
- NCT03687827
- Sponsor
- Novo Nordisk A/S
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-02
- Primary completion
- 2019-12-20
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.